Virtual Symposium - The Nexus of Narcolepsy and Cardiometabolic Risk: Important Considerations and Implications for Management
Several cardiometabolic comorbidities, including overweight/obesity, dyslipidemia, cardiovascular diseases, hypertension, and type 2 diabetes or insulin resistance, are common in patients with narcolepsy.  Often these disorders are overlooked, but they have important implications in the managemen
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
Clinical Brief: Use of Insulin Pumps in the Management of Type 2 Diabetes: A Review of Guidelines and Evidence
This clinical brief, adapted from a presentation at the 2021 CMHC Spring meeting, offers an overview of insulin pumps and insulin delivery systems for T2DM, as well as expert feedback and practical strategies on how to integrate them to patient care.
Category
  • CMHC
Format
  • Monograph
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
Virtual Symposium: Addressing The Disproportionate Burden & Disparities with COVID-19
By now, it is established that the burden of cardiometabolic risk, including CVD, diabetes, atherosclerosis, hypertension, obesity, and more, are higher in certain racial and ethnic minorities, including African Americans, Latinos, and Native Americans.
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
CMHC Annual 2021 On Demand
The global epidemic of cardiometabolic disease demands the continual refinement of cardiometabolic care approaches and strategies. As the nation’s premier event in cardiometabolic medicine, the 16th Annual Cardiometabolic Health Congress
Category
  • CMHC
Format
  • Conference / meeting
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
Virtual Symposium: Lipid Management in Very High-Risk Patients Post-MI: Applying Real-World Evidence to Improve Outcome
Patients with a recent myocardial infarction (MI) are classified as very high-risk for future atherosclerotic cardiovascular disease (ASCVD) events according to current guidelines, however, targeted LDL-C achievement and optimization of lipid lowering therapy (LLT) in these patients remains subop
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
Virtual Symposium- Challenges and Advances in Long-Term Obesity Management: Interpreting and Applying the Evidence to Patient Care
Nearly 40% of adults in the United States are obese: a number that is expected to rise in the near future.  The impacts of obesity are profound, both in terms of increasing cardiometabolic risk as well as exacerbating morbidity and mortality from existing cardiometabolic conditions.  During this
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
Webcast: Cardiorenal Risk Reduction With Novel Non-Steroidal MRAS - Advances and Expert Perspectives
During this activity, experts will discuss recent data about the cardiovascular and renal benefits with novel non-steroidal MRAs in patients with diabetic kidney disease (DKD), including the FIGARO-DKD trial and FIDELITY analysis, as well as their clinical practice implications.
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation
CMHC Masterclass On Demand: Frontiers in Interventional Cardiology
This masterclass is designed to explore the latest advances about the most pertinent domains in interventional cardiology.
Category
  • CMHC
Format
  • Conference / meeting
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
At the Frontiers of Care: The Emerging Role of CGM in Improving Glycemic Control and Outcomes During Pregnancy
Pregnant women with diabetes often require strict glycemic control in order to reduce the possibility of both immediate and long-term maternal and fetal complications, including macrosomia, large or small for gestational age, C-section, neonatal hyperglycemia, and many more
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation
The Emerging Role of CGM for Patients with Type 2 Diabetes: Rationale, Evidence, and Practice Pearls for Integration
Continuous glucose monitoring (CGM) has emerged as a clinically useful tool for the management of patients with type 2 diabetes, as it provides real-time data to better guide glycemic variability, improve glycemic control, as well as reduce the risk of hypoglycemia and hospitalizations.
Category
  • CMHC
Format
  • Video
Credits
  • ABIM MOC and AMA PRA Category 1 Credit
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation

Pages